Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

Hypocholesterolemic Effects of Expeller-Pressed and Solvent-Extracted Fruit Seed Oils and Defatted Pomegranate Seed Meals.

Teh HE, Yokoyama WH, German JB, McHugh TH, Pan Z.

J Agric Food Chem. 2019 Jun 5;67(22):6150-6159. doi: 10.1021/acs.jafc.8b07186. Epub 2019 May 22.

PMID:
31117552
2.

Current pharmacotherapeutic options for primary dyslipidemia in adults.

Cicero AFG, Landolfo M, Ventura F, Borghi C.

Expert Opin Pharmacother. 2019 Jul;20(10):1277-1288. doi: 10.1080/14656566.2019.1604687. Epub 2019 May 6. Review.

PMID:
31059312
3.

Evaluating the efficacy and safety of atorvastatin + ezetimibe in a fixed-dose combination for the treatment of hypercholesterolemia.

Ma YB, Chan P, Zhang Y, Tomlinson B, Liu Z.

Expert Opin Pharmacother. 2019 Jun;20(8):917-928. doi: 10.1080/14656566.2019.1594776. Epub 2019 Mar 25. Review.

PMID:
30908086
4.

Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol.

Ray KK, Bays HE, Catapano AL, Lalwani ND, Bloedon LT, Sterling LR, Robinson PL, Ballantyne CM; CLEAR Harmony Trial.

N Engl J Med. 2019 Mar 14;380(11):1022-1032. doi: 10.1056/NEJMoa1803917.

PMID:
30865796
5.

Efficacy of a fixed dose combination of irbesartan and atorvastatin (Rovelito®) in Korean adults with hypertension and hypercholesterolemia.

Ihm SH, Shin J, Park CG, Kim CH.

Drug Des Devel Ther. 2019 Feb 13;13:633-645. doi: 10.2147/DDDT.S191973. eCollection 2019.

6.

Lipid-lowering drugs.

[No authors listed]

Med Lett Drugs Ther. 2019 Feb 11;61(1565):17-24. No abstract available.

PMID:
30845106
7.

Emerging drugs for the treatment of hypercholesterolemia.

Bove M, Cicero AFG, Borghi C.

Expert Opin Emerg Drugs. 2019 Mar;24(1):63-69. doi: 10.1080/14728214.2019.1591372. Epub 2019 Mar 21. Review.

PMID:
30841759
8.

Efficacy and safety of different doses of alirocumab in reducing low-density lipoprotein cholesterol levels: a network meta-analysis.

Pan R, Li Y, Zhou H.

Pharmazie. 2019 Jan 1;74(1):8-14. doi: 10.1691/ph.2019.8584. Review.

PMID:
30782243
9.

New and Future Parenteral Therapies for the Management of Lipid Disorders.

Garcia R, Burkle J.

Arch Med Res. 2018 Nov;49(8):538-547. doi: 10.1016/j.arcmed.2019.01.001. Epub 2019 Feb 8. Review.

PMID:
30739730
10.

Comparative efficacy and safety of lipid-lowering agents in patients with hypercholesterolemia: A frequentist network meta-analysis.

Zhao Z, Du S, Shen S, Luo P, Ding S, Wang G, Wang L.

Medicine (Baltimore). 2019 Feb;98(6):e14400. doi: 10.1097/MD.0000000000014400.

11.

New Cholesterol Guidelines Personalize Risk and Add Treatments.

Abbasi J.

JAMA. 2019 Feb 26;321(8):731-732. doi: 10.1001/jama.2018.21019. No abstract available.

PMID:
30725107
12.

Comments on the most important and recent studies involving PCSK9i.

Češka R.

Vnitr Lek. Winter 2019;64(12):1137-1141. Review.

PMID:
30704247
13.

Consensus statement of professional associations on prescribing of PCSK9-inhibitors.

Češka R, Táborský M, Vrablík M.

Vnitr Lek. Winter 2019;64(12):1131-1136.

PMID:
30704246
14.

Diagnosis and Management of Statin Intolerance.

Alonso R, Cuevas A, Cafferata A.

J Atheroscler Thromb. 2019 Mar 1;26(3):207-215. doi: 10.5551/jat.RV17030. Epub 2019 Jan 19. Review.

15.

Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis.

Kaplan DE, Serper MA, Mehta R, Fox R, John B, Aytaman A, Baytarian M, Hunt K, Albrecht J, Njei B, Taddei TH; VOCAL Study Group.

Gastroenterology. 2019 May;156(6):1693-1706.e12. doi: 10.1053/j.gastro.2019.01.026. Epub 2019 Jan 18.

16.

Apheresis for severe hypercholesterolaemia and elevated lipoprotein(a).

Waldmann E, Parhofer KG.

Pathology. 2019 Feb;51(2):227-232. doi: 10.1016/j.pathol.2018.10.016. Epub 2019 Jan 2. Review.

PMID:
30611543
17.

Lipid-lowering effects of Coffea arabica pulp aqueous extract in Caco-2 cells and hypercholesterolemic rats.

Ontawong A, Duangjai A, Muanprasat C, Pasachan T, Pongchaidecha A, Amornlerdpison D, Srimaroeng C.

Phytomedicine. 2019 Jan;52:187-197. doi: 10.1016/j.phymed.2018.06.021. Epub 2018 Jun 25.

PMID:
30599898
18.

High Receipt of Statins Reduces the Risk of Lung Cancer in Current Smokers With Hypercholesterolemia: The National Health Insurance Service-Health Screening Cohort.

Kwon YJ, You NY, Lee JW, Kim J, Kang HT.

Clin Lung Cancer. 2019 Mar;20(2):e177-e185. doi: 10.1016/j.cllc.2018.11.009. Epub 2018 Nov 29.

PMID:
30578109
19.

Combination of Berberine with Resveratrol Improves the Lipid-Lowering Efficacy.

Zhu X, Yang J, Zhu W, Yin X, Yang B, Wei Y, Guo X.

Int J Mol Sci. 2018 Dec 6;19(12). pii: E3903. doi: 10.3390/ijms19123903.

20.

The efficacy of double filtration plasmapheresis in the treatment of homozygous familial hypercholesterolemia: A single-center experience.

Albayrak M, Yıldız A, Ateş N, Pala Ç.

Transfus Apher Sci. 2019 Feb;58(1):61-64. doi: 10.1016/j.transci.2018.11.007. Epub 2018 Dec 5.

PMID:
30545658

Supplemental Content

Loading ...
Support Center